2-99578384-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001386135.1(AFF3):āc.2861C>Gā(p.Ser954Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000567 in 1,611,342 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0030 ( 2 hom., cov: 32)
Exomes š: 0.00031 ( 3 hom. )
Consequence
AFF3
NM_001386135.1 missense
NM_001386135.1 missense
Scores
3
6
9
Clinical Significance
Conservation
PhyloP100: 6.34
Genes affected
AFF3 (HGNC:6473): (ALF transcription elongation factor 3) This gene encodes a tissue-restricted nuclear transcriptional activator that is preferentially expressed in lymphoid tissue. Isolation of this protein initially defined a highly conserved LAF4/MLLT2 gene family of nuclear transcription factors that may function in lymphoid development and oncogenesis. In some ALL patients, this gene has been found fused to the gene for MLL. Multiple alternatively spliced transcript variants that encode different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.010810375).
BP6
Variant 2-99578384-G-C is Benign according to our data. Variant chr2-99578384-G-C is described in ClinVar as [Benign]. Clinvar id is 2651184.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 455 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFF3 | NM_001386135.1 | c.2861C>G | p.Ser954Cys | missense_variant | 18/25 | ENST00000672756.2 | NP_001373064.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFF3 | ENST00000672756.2 | c.2861C>G | p.Ser954Cys | missense_variant | 18/25 | NM_001386135.1 | ENSP00000500419 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00297 AC: 452AN: 152218Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
452
AN:
152218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000765 AC: 190AN: 248284Hom.: 1 AF XY: 0.000641 AC XY: 86AN XY: 134206
GnomAD3 exomes
AF:
AC:
190
AN:
248284
Hom.:
AF XY:
AC XY:
86
AN XY:
134206
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000314 AC: 458AN: 1459006Hom.: 3 Cov.: 31 AF XY: 0.000276 AC XY: 200AN XY: 725708
GnomAD4 exome
AF:
AC:
458
AN:
1459006
Hom.:
Cov.:
31
AF XY:
AC XY:
200
AN XY:
725708
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00299 AC: 455AN: 152336Hom.: 2 Cov.: 32 AF XY: 0.00306 AC XY: 228AN XY: 74490
GnomAD4 genome
AF:
AC:
455
AN:
152336
Hom.:
Cov.:
32
AF XY:
AC XY:
228
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
43
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
117
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | AFF3: BP4, BS1, BS2 - |
AFF3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 18, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
M;M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at